Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$7 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-3.8 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
3.2
Industry P/E
54.26
EV/EBITDA
-0.1
Div. Yield
0 %
Debt to Equity
0.2
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
3,184,700
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Heart Test Laboratories Inc. (HSCS)
| -25.6 | -17.4 | -25.6 | -16.4 | 32.6 | -- | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Heart Test Laboratories Inc. (HSCS)
| -19.1 | 2,078.1 | -79.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Heart Test Laboratories Inc. (HSCS)
|
2.3 | 7.2 | 0.0 | -8.5 | -89,802.3 | -292.9 | -- | 3.2 |
| 7.9 | 5,176.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 278.3 | 7,248.3 | 2,554.2 | 319.2 | 19.5 | 4.7 | 9.6 | 1.0 | |
| 36.8 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 112.8 | 6,098.9 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 8.9 | |
| 76.1 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.6 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 330.4 | 12,879.6 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.5 | 9.2 | |
| 117.8 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,409.8 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.1 | 2.6 |
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect... impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas. Address: 550 Reserve Street, Southlake, TX, United States, 76092 Read more
CEO, President & Chairman of the Board of Directors
Mr. Andrew Simpson
CEO, President & Chairman of the Board of Directors
Mr. Andrew Simpson
Headquarters
Southlake, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Heart Test Laboratories Inc (HSCS) is $2.30 (NASDAQ) as of 02-Apr-2026 16:00 EDT. Heart Test Laboratories Inc (HSCS) has given a return of 32.58% in the last 3 years.
Since, TTM earnings of Heart Test Laboratories Inc (HSCS) is negative, P/E ratio is not available.
The P/B ratio of Heart Test Laboratories Inc (HSCS) is 3.22 times as on 31-Mar-2026, a 9 premium to its peers’ median range of 2.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
The 52-week high and low of Heart Test Laboratories Inc (HSCS) are Rs 6.47 and Rs 2.01 as of 04-Apr-2026.
Heart Test Laboratories Inc (HSCS) has a market capitalisation of $ 7 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Heart Test Laboratories Inc (HSCS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.06
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.